Immune cells and signals in enlarged prostate (BPH)

Immune microenvironment in BPH pathogenesis

['FUNDING_OTHER'] · STANFORD UNIVERSITY · NIH-11142401

This project looks at how immune signals in the prostate might cause or worsen BPH in men with prostate enlargement.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorSTANFORD UNIVERSITY (nih funded)
Locations1 site (STANFORD, UNITED STATES)
Trial IDNIH-11142401 on ClinicalTrials.gov

What this research studies

Researchers will compare prostate tissue from men with BPH to normal prostate tissue to find immune-related differences. They will use gene expression profiling and other molecular tests to focus on immune pathways, especially the chemokine CXCL13. The team aims to define immune-related subtypes of BPH that could explain why symptoms develop. Findings may point to new targets for treatments that address disease mechanisms rather than only easing symptoms.

Who could benefit from this research

Good fit: Ideal candidates are men with a clinical diagnosis of BPH or prostate enlargement who can provide tissue samples or join observational studies.

Not a fit: Men whose urinary symptoms are caused by other diagnoses such as prostate cancer or non-prostate conditions may not benefit directly from this research.

Why it matters

Potential benefit: If successful, this work could lead to new targeted therapies for BPH that treat underlying immune-driven causes instead of just relieving symptoms.

How similar studies have performed: Prior gene-expression work has suggested immune involvement in BPH and identified CXCL13 as a lead, but immune-targeted treatments for BPH remain largely unproven.

Where this research is happening

STANFORD, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.